Drug Price Trends for TUSSIN CF COUGH-COLD SYRUP

Average Pharmacy Cost for TUSSIN CF COUGH-COLD SYRUP

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02077	ML	2024-12-18
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02158	ML	2024-11-20
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.01970	ML	2024-10-23
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02063	ML	2024-09-18
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02083	ML	2024-08-21
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02119	ML	2024-07-17
TUSSIN CF COUGH-COLD SYRUP	24385-0904-26	0.02221	ML	2024-06-19

TUSSIN CF COUGH-COLD SYRUP Market Analysis and Financial Projection

Market Analysis and Price Projections for Tussin CF Cough-Cold Syrup

Overview of Tussin CF

Tussin CF is a cough-cold syrup that belongs to the upper respiratory combinations drug class. It is commonly used to relieve symptoms associated with cough, nasal congestion, and other respiratory allergies. The syrup contains a combination of active ingredients, including dextromethorphan, guaifenesin, and phenylephrine, which work as a cough suppressant, expectorant, and nasal decongestant, respectively[5].

Market Size and Growth

The cough remedies market, which includes products like Tussin CF, is projected to grow significantly over the coming years. By 2025, the global cough remedies market is forecast to reach $1.45 billion, growing at a Compound Annual Growth Rate (CAGR) of 3.6% during the period from 2020 to 2025. This growth is driven by factors such as an increase in the geriatric population, rising vehicle pollution, and high demand for over-the-counter (OTC) products[3].

Segment Analysis

The oral syrups segment, which includes Tussin CF, holds a major share in the cough remedies market. This segment is estimated to grow at a CAGR of 4.0% during the forecast period due to the demand for oral syrups in terms of capacity, effectiveness, and quality. Oral syrups are preferred for their pleasant taste and are projected to continue leading the market[3].

Distribution Channels

The distribution channels for cough remedies, including Tussin CF, are diverse and widespread. The market is expected to see significant growth in regions like the Asia-Pacific, driven by rising disposable incomes, the launch of new products, and growing healthcare awareness. In North America, frequent approvals of new cough suppressant drugs by the FDA also contribute to market growth[3][4].

Pricing and Cost

The cost of Tussin CF can vary depending on the pharmacy and the quantity purchased. For example, a 118 milliliter supply of Tussin CF oral liquid can cost around $11.28 to $11.68, with prices per unit ranging from $0.10 to $0.06 for larger quantities[2].

Price Breakdown

• 118 milliliters: $11.28 - $11.68
• 237 milliliters: $13.37 - $14.01

Discounts and Assistance Programs

Consumers can use discount cards, such as the Drugs.com Discount Card, to save up to 80% on the cost of Tussin CF and other medications. However, there are no specific patient assistance programs or manufacturer promotions available for Tussin CF[2].

Drivers of Market Growth

Several factors drive the growth of the cough suppressant drugs market, including Tussin CF:

Increasing Prevalence of Cough Cases

Cough is a common symptom of various upper and lower respiratory tract infections, and its prevalence is high globally. According to the National Center for Biotechnology Information, cough accounts for around 8% of all consultations with primary care physicians and has an annual prevalence of approximately 10–33% in the general population[4].

Approval and Launch of New Drugs

Frequent approvals and launches of new cough suppressant drugs, such as Mucinex DM Maximum Strength, contribute to market growth. These new drugs offer advanced treatments and are indicated for controlling coughs and breaking up mucus, making them more effective and in demand[4].

Regulatory Environment

While stringent regulations, such as the reclassification of codeine as a prescription-only medicine in some countries, can affect market growth, the overall trend in North America, particularly with FDA approvals, supports the expansion of the cough suppressant drugs market[4].

Challenges and Risks

Microbial Contamination

Recent recalls, such as the one issued by Haleon for Robitussin Honey CF Max due to microbial contamination, highlight the risks associated with cough syrups. Such recalls can impact consumer trust and market stability, although they are typically isolated incidents[1].

Regulatory Restrictions

Stringent regulations, especially those related to the use of certain ingredients like codeine, can restrict market growth. For instance, the reclassification of codeine as a prescription-only medicine in Australia has affected the availability of OTC cough suppressants[4].

Regional Market Analysis

North America

North America is expected to hold a dominant position in the cough suppressant drugs market due to frequent FDA approvals of new drugs. This region sees significant investment in research and development, leading to the introduction of advanced cough remedies[4].

Asia-Pacific

The Asia-Pacific region is expected to grow at a higher CAGR during the forecast period, driven by rising disposable incomes, new product launches, and growing healthcare awareness. The increasing geriatric population in countries like India and China also contributes to the demand for cough remedies[3].

Key Takeaways

• Market Growth: The cough remedies market, including Tussin CF, is projected to reach $1.45 billion by 2025, growing at a CAGR of 3.6%.
• Segment Dominance: Oral syrups, such as Tussin CF, hold a major share in the market and are expected to continue leading.
• Pricing: The cost of Tussin CF varies but is generally around $11 for a 118 milliliter supply.
• Drivers: Increasing cough cases, new drug approvals, and growing healthcare awareness drive market growth.
• Challenges: Microbial contamination risks and regulatory restrictions can impact market stability.

FAQs

What are the active ingredients in Tussin CF?

Tussin CF contains dextromethorphan, guaifenesin, and phenylephrine, which act as a cough suppressant, expectorant, and nasal decongestant, respectively[5].

How much does Tussin CF typically cost?

The cost of Tussin CF can range from $11.28 to $11.68 for a 118 milliliter supply, depending on the pharmacy[2].

What factors drive the growth of the cough suppressant drugs market?

The growth is driven by increasing cough cases, frequent approvals and launches of new drugs, and growing healthcare awareness[3][4].

Are there any patient assistance programs available for Tussin CF?

No specific patient assistance programs or manufacturer promotions are available for Tussin CF, but consumers can use discount cards to reduce costs[2].

How does the regulatory environment impact the market?

Stringent regulations, such as the reclassification of codeine, can affect market growth, but FDA approvals in North America support the expansion of the cough suppressant drugs market[4].

What regions are expected to see significant growth in the cough remedies market?

North America and the Asia-Pacific region are expected to see significant growth, driven by FDA approvals and rising disposable incomes, respectively[3][4].